Dr Laczka obtained a PhD in Biotechnology from the Autonomous University of Barcelona, Spain, in 2009, after completing a master’s degree in applied biotechnology and microbiology and a bachelor’s degree in biological sciences in France. For the first part of his career, Olivier conducted research as an academic, in Spain and Australia, where he was able to successfully develop diagnostic tools toward a wide range of applications, going from medical and food diagnostics to both terrestrial and marine monitoring devices, generating over 25 peer-reviewed research articles and a patent. In 2012, he was awarded the prestigious University of Technology Sydney (UTS) Vice Chancellor’s Postdoctoral Research Fellowship, which enabled him to carry out extensive independent research on the development of novel methods toward the detection of human pathogens. Dr Laczka’s expertise covers an extensive range of technical skills in microscopy, chemical, electrochemical and optical methods, microbiology, biochemistry, immunology, and molecular biology. In 2015, he joined the Biopharmaceutical industry as a senior research scientist, where he successfully managed and completed therapeutic drug development projects within GLP and cGMP environments, following the current regulatory requirements for early stages of drug development. Dr Laczka’s multidisciplinary background allows him to drive projects covering a wide range of technologies and indications. Throughout his career, Olivier has developed an extensive experience in people and project management, as well as interacting with academic, government, and private entities or individuals, at the international level. His scientific writing experience has also allowed him to attract significant amounts of research funding over the years, through collaborations and partnerships with private entities and government organizations.